LVSI positive and NX in early endometrial cancer: Surgical restaging (and no further treatment if N0), or adjuvant ERT?
- 1 January 2020
- journal article
- review article
- Published by Elsevier in Gynecologic Oncology
- Vol. 156 (1) , 243-250
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- External Pelvic and Vaginal Irradiation Versus Vaginal Irradiation Alone as Postoperative Therapy in Medium-Risk Endometrial CarcinomaInternational Journal of Gynecological Cancer, 2012
- Histologic Artifacts in Abdominal, Vaginal, Laparoscopic, and Robotic Hysterectomy SpecimensAmerican Journal of Surgical Pathology, 2011
- Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer – Results from two randomised studiesEuropean Journal of Cancer, 2010
- Evaluation of vascular space involvement in endometrial adenocarcinomas: laparoscopic vs abdominal hysterectomiesLaboratory Investigation, 2010
- Intravaginal Brachytherapy in FIGO Stage I Low-Risk Endometrial CancerInternational Journal of Gynecological Cancer, 2009
- Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysisThe Lancet, 2009
- Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised studyThe Lancet, 2009
- Prospective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical stagingGynecologic Oncology, 2008
- Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trialBritish Journal of Cancer, 2006
- A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group studyGynecologic Oncology, 2004